Background Few studies have evaluated the performance of existing breast cancer risk prediction models among women of African ancestry. In replication studies of genetic variants, a change in direction of the risk association is a common phenomenon. Termed flip-flop, it means that a variant is risk factor in one population but protective in another, affecting the performance of risk prediction models. Methods We used data from the genome-wide association study (GWAS) of breast cancer in the African diaspora (The Root consortium), which included 3686 participants of African ancestry from Nigeria, USA, and Barbados. Polygenic risk scores (PRSs) were constructed from the published odds ratios (ORs) of four sets of susceptibility loci for breast cancer. Discrimination capacity was measured using the area under the receiver operating characteristic curve (AUC). Results Flip-flop phenomenon was observed among 30~40% of variants across studies. Using the 34 variants with consistent directionality among previous studies, we constructed a PRS with AUC of 0.531 (95% confidence interval [CI]: 0.512-0.550), which is similar to the PRS using 93 variants and ORs from European ancestry populations (AUC = 0.525, 95% CI: 0.506-0.544). Additionally, we found the 34-variant PRS has good discriminative accuracy in women with family history of breast cancer (AUC = 0.586, 95% CI: 0.532-0.640). Conclusions We found that PRS based on variants identified from prior GWASs conducted in women of European and Asian ancestries did not provide a comparable degree of risk stratification for women of African ancestry. Further large-scale finemapping studies in African ancestry populations are desirable to discover population-specific genetic risk variants.
Introduction
Breast cancer is the most common cancer in women worldwide with a total of nearly 2.2 million new cases diagnosed in 2015 [1] . To date, genome-wide association studies (GWAS) have revealed approximately 100 common single-nucleotide polymorphisms (SNPs) associated with breast cancer risk [2] [3] [4] [5] . The combined effect of these SNPs has been shown to achieve a reasonable degree of risk stratification in populations Shengfeng Wang and Frank Qian have contributed equally to this paper.
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of European ancestry [6] [7] [8] . Significant SNPs can be aggregated into risk prediction models in the form of polygenic risk score (PRS), which can be used for the identification of highrisk individuals in clinical settings and for population-level screening [9, 10] .
To date, SNPs from GWAS have been identified almost exclusively in populations of European ancestry, and often show different association patterns among African populations [11] [12] [13] . Even among women of African ancestry, variants identified in one population are often not applicable to another population [14] . These conflicting results could be due to several reasons, including differences in allele frequencies and linkage disequilibrium (LD) blocks among different ethnicities [15] , and differences in population characteristics within one ethnicity. The flip-flop phenomenon, meaning that the same allele confers risk in one population but is protective in another, has been observed as hindrance to drawing causal inference in replication studies of gene-disease associations [16] . To date, few studies have evaluated breast cancer risk prediction model with SNPs identified among women of African ancestry [17] , and to our knowledge, none of the previous studies incorporated the flip-flop phenomenon to compare the model's performance for in populations of African ancestry.
In the present study, we had two main aims: (1) To examine the flip-flop phenomenon in approximately 100 previously identified risk variants in women of African ancestry; (2) to construct several PRSs with aforementioned SNPs, based on consistency among ancestry and studies, and compare their performances in women of African ancestry.
Methods

Study participants
The study populations of the Root Consortium have been described previously [11, 18] _ENREF_22_ENREF_22. Briefly, this study included 3686 participants of African ancestry (1657 breast cancer cases and 2029 controls). Ascertainment of cases and controls occurred in Ibadan, Nigeria (711 cases and 624 controls), Barbados (92 cases and 229 controls), and four sites in the United States (854 cases and 1176 controls). The mean age of cases was 49.3 years, whereas the mean age of controls was 48.4 years. Other baseline characteristics such as menopausal status and family history of breast cancer are presented in Supplemental Table 1 .
SNP genotyping and imputation and ancestry estimation
Information about genotyping, quality control, imputation, and principal component analysis (PCA) has been previously described [11] . Briefly, genotyping was conducted using the Illumina HumanOmni2.5-8v1 array, including approximately 2.4 million genetic variants. Genotype imputation was conducted with the IMPUTE2 software. With the 1000 Genomes Project phase 1 integrated variant set as the reference panel, 23,098,723 SNPs were imputed and passed the imputation quality filter (imputation score > 0.3). To account for population structure, the first ten principal components were computed with the smartpca program in the EIGENSOFT package [19] .
Statistical analysis
Approximately 100 SNPs have been used for the creation of breast cancer PRS as of March 1, 2017 , and most of those were significantly associated with breast cancer risk at a genome-wide level of significance (Supplemental Table 2 ) [6, 17] . We calculated the flip-flop proportion of these SNPs, among Root Consortium and three published studies, including African-American Breast Cancer Consortium (AABC), the Women's Health Initiative (WHI), and Breast Cancer Association Consortium (BCAC, with women of European ancestry) [2, 6, 12, 13, 17] . The proportion of flip-flop was calculated as the number of SNPs with the point value of odds ratios (ORs) in opposite direction between any two studies divided by the total number of SNPs tested. The point value of ORs in opposite direction means that the point value of OR for a specific SNP is greater than 1 in one study but smaller than 1 in others, and vice versa.
PRS was calculated as the weighted sum of risk alleles [20] . We created a PRS for each individual based on the genotype at each locus, defined as PRS = ∑
where n ij is the number of risk alleles carried by individual j at the ith SNP and OR i is the per-allele odds ratio associated with the ith SNP. To remove potential bias from ancestry admixture, PRS residuals were then calculated after regression of the score on 10 principal components. This ancestry-adjusted PRS was used for further analysis. A total of 9 PRSs were generated based on different combinations of SNPs and ORs derived from BCAC with European ancestry and two consortia of women of African ancestry: WHI and AABC [2, 6, 12, 13, 17] . The Root study was taken as target sample to validate each PRS's performance. SNPs and corresponding ORs used in the calculation of PRSs are summarized in Supplemental Table 2 .
We assessed the association of these PRSs with overall breast cancer risk as well as in subgroups of ER status (ER+ or ER−), country of origin (Nigerian, African American/ African Barbadian), family history of breast cancer (yes, no), and age groups (< 40, 40-59, ≥ 60). Both continuous and categorical risk scores were examined in relation to breast cancer risk using unconditional logistic regression. Odds ratios per 1 unit standard deviation (SD) and odds ratios by percentile of PRSs, with the middle quintile (40th-60th percentiles) as the reference group, were estimated from logistic regressions. Receiver operating characteristic (ROC) analysis was conducted and discrimination between cases and controls was measured using the area under the ROC curve (AUC). We tested the equality of ROC areas obtained from applying nine PRSs to the same sample using the method by DeLong et al. [21] . Statistical analysis was conducted using Stata 15.0 (StataCorp, College Station, TX). A two-sided P value of < 0.05 was considered statistically significant.
Results
The percentages of flip-flop associations between women of European ancestry (BCAC) and women of African ancestry were 27, 31, and 29% for WHI, AABC, and Root, respectively ( Fig. 1 ). Among women of African ancestry, the percentages of flip-flop associations between Root, WHI, and AABC study ranged from 33% to 41% (Fig. 1 ). There were 45 SNPs in the same direction between WHI and AABC (Supplemental Table 2 ). If further compared to the ORs from BCAC, the number of SNPs in the same direction across all three studies became 34. A total of 23 SNPs maintained the same direction in all four datasets.
We evaluated nine PRSs using the SNP panels from previous studies or the flip-flop analysis mentioned above ( Table 1 ). The performance of the nine PRSs was weak in distinguishing cases and controls, and there was no statistical difference across the nine models (P = 0.16). Of the four PRSs based on a single previous study, the PRS that included 93 SNPs (model 4) had the largest AUC value (0.524, 95% CI 0.506-0.544) for overall breast cancer risk. Of the five PRSs based on results of flip-flop analysis, the PRS that included 34 SNPs with OR estimates from WHI (model 7) had the largest AUC (0.531, 95% CI 0.512-0.550).
In stratified analysis, a positive family history of breast cancer was associated with increased risk of breast cancer (OR 1.96, 95% CI 1.59-2.41). None of the nine PRSs was correlated with family history of breast cancer, and thus there was no attenuation in odds ratio for family history after adjusting for the PRS (data not shown). The joint effects of the PRSs and family history are shown in Table 2 . Interestingly, the AUCs for all the PRSs were greater in women with positive family history of breast cancer than those in women without family history (Table 2 ). For example, the 34-SNP PRS has a moderate discriminative capacity among women with family history of breast cancer (AUC = 0.586); there was about 4.74-fold difference in breast cancer risk between women with the top 10 th PRS and women with the bottom 10% of PRS (Supplemental Table 3 ).
We further examined the performance of the 93-SNP and 34-SNP PRSs according to demographic and clinical characteristics. The performance of the 93-SNP PRS was better in Nigerian women than in African-American/African Barbadian women (P interaction = 0.019), though this was not observed for the 34-SNP PRS (P interaction = 0.64) ( Table 3) . On the other hand, we observed no significant differences across age groups for both the 93-SNP (P interaction = 0.58) nor the 34-SNP PRSs (P interaction = 0.74). Both the 93-SNP PRS and the 34-SNP PRS were strongly associated with ER+ breast cancer (OR per unit SD = 1.17 and 1.14, respectively), but their associations with ER− disease were weak and not statistically significant (Table 4) . 
Discussion
We found that the proportion of flip-flop phenomenon was about 30~40% regardless of whether assessing within women of African ancestry or across racial/ethnic groups. The PRS based on a subset of 34 SNPs with consistent direction among previous studies demonstrated similar risk prediction as the PRS based on 93 SNPs from European ancestry populations. However, the discriminative performance of these PRSs was still low for women of African ancestry. On the other hand, the PRSs offered good discriminative capacity for women with family history of breast cancer. The proportion of flip-flop phenomenon was approximately 30-40% when comparing the three studies in women of African ancestry or across different ethnic groups. One possible explanation was that the results of these three studies of African ancestry were limited by statistical power. The P value thresholds for GWAS studies in African or African-American population were suggested to be more stringent due to the greater genetic diversity in these populations [22] , and the flip-flop associations within the same ethnic group are likely to be spurious [16] . Ntzani et al. evaluated the discrepancies for ancestral effect sizes for confirmed GWAS-identified associations obtained from GWAS catalog, and they reported a slight lower discrepancy proportion of 21% between European ancestry and African ancestry, while the percentages of flip-flop associations in our study ranged from 27 to 31% [23] . As discussed in their paper, the flip-flop associations across different ethnic groups have two interpretations. First, it could indicate that the heterogeneity of the same variant could be due to differences in genetic background or environmental factors across populations [16] . It is unlikely that all of the flip-flop associations could be attributed to these differences and instead indicates that some variants could be false positives, demonstrating the importance of validation studies in populations across different ancestries [24] . Second, as Wen et al. proposed, the SNPs without flip-flop association across different ethnic groups are more likely to be correlated with the disease outcome and could be true causal variants [25] . In their paper, only 44 internally confirmed SNPs were applied to construct a PRS for women of Asian ancestry, and the performance of 44-SNP PRS was very close to 88-SNP PRS in their data (AUC: 0.606 vs. 0.609).
In the present study, several PRSs constructed using published breast cancer susceptibility loci demonstrated inadequate predictive value for breast cancer risk assessment among women of African ancestry. The PRS of 77 SNPs developed in European ancestry populations yielded an AUC of 0.615 in a validation sample of Caucasians [6] . When this PRS was directly applied to women of African ancestry, the AUC was only 0.516. The best performed PRSs in our study (AUC ≈ 0.53) had discriminative accuracy similar to Allman's study (AUC = 0.55, 95% CI 0.53-0.58), which was conducted using 7539 African-American women from WHI [17] . Our study included both African Americans and women of African ancestry living in Nigeria and Barbados. We found an interesting phenomenon that the PRSs performed better in Nigerian individuals than in African Americans and Africans in the Caribbean. A potential explanation is that spurious association may occur with an adjustment only for global ancestry or mixed ancestry, and further local ancestry adjustment might be needed to sufficiently control population stratification in populations like African Americans [26] .
Furthermore, we noted that the PRS including only 34 SNPs, all with the same association direction among previous studies, performed equally well as the PRS including 93 SNPs. This result supports our hypothesis that the performance of PRS based on a subset of SNPs without flip-flop is non-inferior since it avoids the inclusion of SNPs that may be false positives. In order to apply a PRS as population-level screening tool, cost-effectiveness should also be considered [27] . Our study provides a possible strategy to identify women at increased risk for breast cancer with only 1/3 of the known index SNPs. This cost-saving may be considered when performing genetic testing among women at average breast cancer risk [9] .
Another interesting finding is that the common genetic variant-based PRSs performed better for women with a positive family history of breast cancer. We estimated the AUC for the 34-SNP PRS to be 0.586 and there could be 4.74-fold risk difference between individuals in the top 10% of the PRS and individuals in the bottom 10%. This is consistent with a previous study conducted in familial cancer clinics in Australia, which demonstrated that a 22 SNPs-based polygenic risk score can distinguish familial breast cancer cases who are negative for BRCA1 or BRCA2 mutation from controls (AUC = 0.654) [28] . These findings suggest that common genetic variants have potential for risk stratification in women with positive family history of breast cancer, especially those who tested negative for BRCA1 or BRCA2, among other established genetic mutations.
To the best of our knowledge, this is the first study to describe the prevalence of the flip-flop phenomenon not only across racial groups but within different ethnic groups of women of African ancestry, and confirms the non-inferiority of PRS only using SNPs showing consistent associations. However, some limitations should be considered when interpreting our study findings. We only assessed the index SNPs from GWAS among non-African Americans. Large-scale fine-mapping studies conducted in women of African ancestry may be needed to identify additional genetic variants at these loci and could be beneficial for population-specific PRS model development. Second, there are multiple reasons for the flip-flop phenomenon, including the interplay of genetic loci and environmental factors or interaction between multiple loci among populations of different ancestries, different LD architectures, sampling variations, and spurious associations [16, 23, 29, 30] . Because our main aim was to apply flip-flop information into genetic risk prediction, we could not pinpoint the exact reasons of flip-flop phenomenon in this study. Further studies on the interaction between genetic variants and environmental factors or between multiple genetic variants (epistasis) are desirable to identify biological reasons underlying the flipflop phenomenon.
In conclusion, our study serves to illustrate the complexity of applying current GWAS findings across diverse racial/ ethnic groups. We observed significant flip-flop in women of African ancestry using SNPs from prior GWAS conducted predominantly in women of European ancestry. Given the poor discriminative ability of currently existing PRS for women of African ancestry, we believe there are two direct implications. One is to discover additional SNPs that have true causal associations or indicate breast cancer risk among women of African ancestry by increasing the sample size coupled with fine-mapping and pathway analysis approaches [24, 31] . Another implication is to develop PRS for predicting familial breast cancer, since our study showed strong predictive value among these women.
